Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CRMD · against 437 other Healthcare companies of similar size
Ranked #319 of 438 · scores higher than 27% of peers · safety percentile 30
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)36 peers with a safety percentile of 20–29, including CRMD · Click a bar to see the companies
Mainly because of its beta, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CRMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 406 reported | 0.32× | 0.19× | 39% | 33% | |
| BetaLower is better · 421 reported | 1.41 | 0.45 | 11% | 33% | |
| Current ratioHigher is better · 431 reported | 2.56× | 2.88× | 45% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 421M USD | 99 | 52 | |
| 2 | 261M USD | 99 | 97 | |
| 3 | 397M USD | 99 | 37 | |
| 4 | 455M USD | 99 | 53 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 315 | 354M USD | 31 | 13 | |
| 316 | 44.2B JPY (≈$301M) | 31 | 64 | |
| 317 | 3.5B CNY (≈$496M) | 31 | 18 | |
| 318 | 787M USD | 30 | 57 | |
| 319 | 433M USD | 30 | 81 | |
| 320 | 327M USD | 30 | 11 | |
| 321 | 551M USD | 30 | 27 | |
| 322 | 110.9B JPY (≈$754M) | 30 | 59 | |
| 323 | 101.2B JPY (≈$688M) | 29 | 54 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score